Condition

Pediatric Migraine 

Age Group

6 - 17 yrs.

Gender

Both male and female

Inclusion

• Have been experiencing migraines for at least 6 months

• Experience between 1 and 14 migraine attacks per month

Length / Duration

• The study will include 2-3 visits to a study site in your location.

• Your or your child’s participation may be as short as several weeks or for up to 6 months.

• After completing this study, you or your child may have the opportunity to participate in the extension study for approximately 1 year.

Compensation 

• Subjects will be compensated for time and travel at the end of each study visit.

• All study-related procedures and study medication will be provided at no cost.

• Health insurance is not required for participation.

Additional Information

The PERISCOPE Study is evaluating an investigational product for the treatment of migraines in children and adolescents between the ages of 6 to 17. The investigational product is currently approved to treat migraines in adults.